Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 37,500 shares, a growth of 24.6% from the January 31st total of 30,100 shares. Based on an average trading volume of 20,836,400 shares, the days-to-cover ratio is currently 0.0 days.

Q BioMed Price Performance

Shares of QBIO stock remained flat at $0.01 during trading hours on Friday. 401,719 shares of the stock were exchanged, compared to its average volume of 6,706,117. The business has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.02. Q BioMed has a 52-week low of $0.00 and a 52-week high of $0.47.

About Q BioMed

(Get Rating)

Q BioMed, Inc operates as a biomedical acceleration and development company. It focuses on acquiring and in-licensing pre-clinical, clinical-stage and approved life sciences therapeutic products. Its products include Strontium-89, MetastronTM, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.

Read More

• Get a free copy of the StockNews.com research report on Q BioMed (QBIO)
• MarketBeat Week in Review – 2/27 – 3/3
• The 3 Most Upgraded Stocks Are Reversing
• How to Find Blue Chip Dividend Stocks
• Zscaler, Inc Plummets, Is It Time To Buy The Dip?
• What is a Good Dividend Yield? How to Decide

Receive News & Ratings for Q BioMed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q BioMed and related companies with MarketBeat.com's FREE daily email newsletter.